SCHEMBL3774554

SCHEMBL3774554

CC(C)N1CCN(C(=O)CN2CCN(c3cccc(C(F)(F)F)c3)CC2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.61
KMT2A Q03164 3/20 0.59
MEN1 O00255 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
MAPT P10636 6/20 0.56
LMNA P02545 5/20 0.56
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 1/20 0.56
TSHR P16473 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
HTT P42858 2/20 0.55
GAA P10253 1/20 0.54
NCOA1 Q15788 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
NCOA3 Q9Y6Q9 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765308 0.91 POLB (0.58) POLBKMT2AMEN1CYP1A2CYP3A4
SCHEMBL3767801 0.86 ME2 (0.57) KMT2AMEN1NPSR1MAPTLMNA
SCHEMBL3762728 0.85 MAPT (0.56) KMT2AMEN1CYP2D6CYP2C9CYP2C19
SCHEMBL3770042 0.84 MEN1 (0.73) KMT2AMEN1NPSR1MAPTALDH1A1
SCHEMBL3765839 0.84 ALDH1A1 (0.58) KMT2AMEN1NPSR1MAPTLMNA
SCHEMBL11914802 0.83 ALDH1A1 (0.60) POLBKMT2AMEN1NPSR1MAPT
SCHEMBL3762814 0.82 MAPT (0.78) KMT2AMEN1NPSR1MAPTLMNA
SCHEMBL3774351 0.82 GFER (0.62) KMT2AMEN1NPSR1MAPTLMNA
Hydrochloric Acid SCHEMBL10995610 0.82 MAPT (0.61) POLBKMT2AMEN1NPSR1MAPT
Hydrochloric Acid SCHEMBL11249767 0.82 MAPT (0.61) POLBKMT2AMEN1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 POLB 4363/4885KMT2A 242/4885MEN1 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.